Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

213 Episodio

  1. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Pubblicato: 29/9/2021
  2. How to Assess Psychotropic Drug Adherence

    Pubblicato: 24/9/2021
  3. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Pubblicato: 19/9/2021
  4. Delirium, Catatonia, and COVID-19

    Pubblicato: 14/9/2021
  5. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Pubblicato: 9/9/2021
  6. Dopamine and Depression: Clinical Considerations

    Pubblicato: 4/9/2021
  7. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Pubblicato: 30/8/2021
  8. New Somatic Treatments for Child and Adolescent Depression

    Pubblicato: 25/8/2021
  9. Management of Delirium: Nonpharmacologic Strategies

    Pubblicato: 20/8/2021
  10. Emerging Complementary and Integrative Therapies for Geriatric Mental Health

    Pubblicato: 15/8/2021
  11. Delirium: Assessment, Consequences, and Sequelae

    Pubblicato: 10/8/2021
  12. In Search of a Dose-Response Relationship in SSRIs

    Pubblicato: 5/8/2021
  13. Valproate/Divalproex: Metabolism, Kinetics, and Warnings

    Pubblicato: 31/7/2021

11 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site